Becky is vice president of clinical operations at Latigo Biotherapeutics, where she leads late-phase clinical development and oversees the execution of Phase 2 and Phase 3 studies. She partners closely with cross-functional teams to support operational excellence, regulatory compliance, and high-quality trial execution as programs advance toward pivotal milestones.

Becky brings more than 20 years of experience in clinical trials operations, with deep expertise in pain and analgesia. Since 2012, she has led more than 25 clinical trials in this complex therapeutic area. Her experience also spans psychology, respiratory disease, dermatology, oncology, and genetic and rare disorders.

Prior to joining Latigo, Becky spent more than a decade at Rho (a clinical research organization specializing in pain studies), most recently serving as vice president of project delivery. In this role, she was recognized as an operational expert in pain and analgesia, providing executive oversight for late-stage clinical programs and advising sponsors on program-level risk mitigation and trial execution.

Becky holds a B.S. from East Carolina University and a Regulatory Affairs Certification from the Regulatory Affairs Professionals Society.